Market revenue in 2024 | USD 8.9 million |
Market revenue in 2030 | USD 23.6 million |
Growth rate | 17.8% (CAGR from 2025 to 2030) |
Largest segment | Gene panel, ldt & others |
Fastest growing segment | Liquid Biopsy |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Liquid Biopsy, Gene Panel, LDT & Others |
Key market players worldwide | Illumina Inc, Exact Sciences Corp, Foundation Medicine, Guardant Health Inc, Burning Rock Biotech Ltd ADR, Freenome, AnchorDx, GeneCast, Elypta |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to multi cancer early detection market will help companies and investors design strategic landscapes.
Gene panel, ldt & others was the largest segment with a revenue share of 110.11% in 2024. Horizon Databook has segmented the Argentina multi cancer early detection market based on liquid biopsy, gene panel, ldt & others covering the revenue growth of each sub-segment from 2018 to 2030.
Constant developments by market players, such as geographic expansion and new product launches, have contributed to Argentina’s market growth. For instance, Amoy Diagnostics Co Ltd. entered into a collaboration agreement with Merck KGaA to bring liquid biopsy RAS biomarker tests to Argentina, Mexico, India, and Brazil.
Initially, the test would be made available for research use only until it gets regulatory authorization from the respective countries. In addition, the country has a higher burden of cancer and the rising prevalence of cancer among the population is propelling the demand for adoption of cancer screening tests.
Moreover, Latin America has seen a steady rise in the number of oncologists, especially in Brazil and Argentina, as well as awareness of the region's chronic scarcity of cancer specialists. To enhance and promote the initiative's activities in the region, a regional hub for Latin America has been established at the National Cancer Institute of Argentina (Instituto Nacional del Cancer de Argentina) in Buenos Aires.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina multi cancer early detection market , including forecasts for subscribers. This country databook contains high-level insights into Argentina multi cancer early detection market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account